Tacrolimus versus anti-tumor necrosis factor agents for steroid-refractory active ulcerative colitis based on the severity of endoscopic findings: a single-center, open-label cohort study

Tacrolimus versus anti-tumor necrosis factor agents for steroid-refractory active ulcerative colitis based on the severity of endoscopic findings: a single-center, open-label cohort study

Satohiro Matsumoto, Haruna Kawamura, Takeshi Nishikawa, Noriyoshi Sagihara, Hiroyuki Miyatani, Hirosato Mashima Department of Gastroenterology, Saitama Medical Center, Jichi Medical University, Saitama, Saitama, Japan Background and aims: At Saitama Medic...

Full description

Bibliographic Details
Main Authors: Matsumoto S, Kawamura H, Nishikawa T, Sagihara N, Miyatani H, Mashima H
Format: Article
Language:English
Published: Dove Medical Press 2017-09-01
Series:Clinical and Experimental Gastroenterology
Subjects:
Ulcerative colitis
Tacrolimus
Anti-tumor necrosis factor agents
Steroid-refractory
Online Access:https://www.dovepress.com/tacrolimus-versus-anti-tumor-necrosis-factor-agents-for-steroid-refrac-peer-reviewed-article-CEG

Internet

https://www.dovepress.com/tacrolimus-versus-anti-tumor-necrosis-factor-agents-for-steroid-refrac-peer-reviewed-article-CEG

Similar Items